Literature DB >> 11173005

Heterogeneity in genetic susceptibility to prostate cancer.

O Cussenot1, A Valeri.   

Abstract

The incidence of prostate cancer is related to aging. Its increase in the last 10 years, varies from country to country and according to ethnic group, with its greatest incidence among African-American males and the least among Asian males. Only two risk factors have thus far been clearly established for prostate cancer: familial aggregation and ethnic origin. No dietary or environmental cause has yet been identified for prostate cancer. However, some variations in endogenous factors, such as sex steroids or IGF1 circulating levels, may partly explain differences in risk observed between different populations. Genetic polymorphisms of genes encoding for 5alpha-reductase, androgen receptor, or vitamin D receptor have been associated with different degrees of risk for prostate cancer and may explain variations in risk among ethnic groups or within geographic areas. Different studies support the theory that familial prostate cancer may be hereditary and not due to a similar lifestyle. Thus, familial inheritance is a parameter that must be considered when advising screening in high-risk families. Indeed, the relative risk for first-degree relatives of prostate cancer patients can reach 2, 5 and 11 when, respectively, 1, 2 and 3 first-degree relatives are affected. Some familial forms appear to be associated with transmission of a rare, putative, autosomal dominant gene (0.003-0.06 allele frequency) with a high penetrance (88% at age 85). Using this transmission model and linkage analysis, three predisposing loci on chromosome 1: HPC-1 (hereditary prostate cancer 1: 1q24-25), PCaP (predisposing for prostate cancer: 1q42-43) and CAPB (predisposing for prostate and brain tumor: 1p36) and one locus on chromosome 20 (HPC20: 20q13) have been described. Moreover, X-linked transmission has been suggested and related to another predisposing gene locus: HPCX (Xq27-28). It is possible that a large proportion of familial prostate cancer is due not to segregation of a few major gene mutations transmitted according to a monogenic inheritance, but rather to familial sharing of alleles at many loci, each contributing to a small increase in cancer risk.

Entities:  

Year:  2001        PMID: 11173005     DOI: 10.1016/s0953-6205(00)00136-9

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  10 in total

1.  A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.

Authors:  Agnes B Baffoe-Bonnie; Jeffrey R Smith; Dietrich A Stephan; Johanna Schleutker; John D Carpten; Tommi Kainu; Elizabeth M Gillanders; Mika Matikainen; Tanya M Teslovich; Teuvo Tammela; Raman Sood; Andrew M Balshem; Sheehan D Scarborough; Jianfeng Xu; William B Isaacs; Jeffrey M Trent; Olli-P Kallioniemi; Joan E Bailey-Wilson
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

2.  Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans.

Authors:  Kristin Gunderson; Christopher Y Wang; Ruoxiang Wang
Journal:  Cancer Epidemiol       Date:  2010-12-16       Impact factor: 2.984

3.  [Ten years national research project "familial prostate cancer": problems in identifying risk families].

Authors:  K Herkommer; C Schmidt; J E Gschwend
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

4.  Racial/Ethnic Disparities in Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by U.S. Census Region and Age Group, 2012-2015.

Authors:  Siddharth Iyengar; Ingrid J Hall; Susan A Sabatino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-17       Impact factor: 4.254

Review 5.  Androgen receptor signaling and mutations in prostate cancer.

Authors:  Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2010-08-16       Impact factor: 3.285

Review 6.  Prostate cancer in Asian men.

Authors:  Kazuto Ito
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

7.  Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.

Authors:  Kewei Wang; Guosheng Wu; Jinping Li; Wentao Song
Journal:  BMC Cancer       Date:  2016-08-23       Impact factor: 4.430

8.  Incidental prostate cancer at the time of cystectomy: the incidence and clinicopathological features in Chinese patients.

Authors:  Jiahua Pan; Wei Xue; Jianjun Sha; Hu Yang; Fan Xu; Hanqing Xuan; Dong Li; Yiran Huang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

9.  Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.

Authors:  Florence Menegaux; Antoinette Anger; Hasina Randrianasolo; Claire Mulot; Pierre Laurent-Puig; François Iborra; Jean-Pierre Bringer; Benoit Leizour; Rodolphe Thuret; Pierre-Jean Lamy; Xavier Rébillard; Brigitte Trétarre
Journal:  BMC Cancer       Date:  2014-02-19       Impact factor: 4.430

10.  Association between PSA and age in Macuxi ethnic population of the Brazilian Amazon forest region.

Authors:  Mário Maciel de Lima; Sebastião Salazar Jansem Filho; Marcos Tobias-Machado
Journal:  Res Rep Urol       Date:  2018-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.